Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) was the target of a significant growth in short interest in February. As of February 13th, there was short interest totaling 942,815 shares, a growth of 71.0% from the January 29th total of 551,455 shares. Based on an average trading volume of 1,079,680 shares, the short-interest ratio is currently 0.9 days. Currently, 1.5% of the shares of the stock are short sold. Currently, 1.5% of the shares of the stock are short sold. Based on an average trading volume of 1,079,680 shares, the short-interest ratio is currently 0.9 days.
Analysts Set New Price Targets
A number of research analysts recently commented on BIOX shares. Wall Street Zen raised Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Canaccord Genuity Group reduced their price target on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a report on Friday, January 2nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, December 29th. One analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $4.00.
View Our Latest Research Report on BIOX
Institutional Inflows and Outflows
Bioceres Crop Solutions Trading Up 1.8%
Shares of BIOX traded up $0.01 during midday trading on Friday, hitting $0.56. The stock had a trading volume of 746,648 shares, compared to its average volume of 770,417. The stock’s 50 day moving average is $1.00 and its 200 day moving average is $1.60. The firm has a market cap of $35.41 million, a PE ratio of -0.67 and a beta of 0.50. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.94 and a quick ratio of 0.64. Bioceres Crop Solutions has a 1 year low of $0.53 and a 1 year high of $5.40.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Featured Stories
- Five stocks we like better than Bioceres Crop Solutions
- 3 Signs You May Want to Switch Financial Advisors
- Your name isn’t on our protected list yet
- Unlocked: Elon Musk’s Next Big IPO
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
